Antitumor effects of curcumin prodrug (IMAGE)
Caption
The high conversion rate of curcumin prodrug TBP1901 to curcumin in bone marrow warrants its clinical application for diseases growing in the marrow like multiple myeloma and leukemia. The natural polyphenol curcumin has shown promising efficacy with tumors in a number of preclinical models.
Credit
KyotoU / Global Comms
Usage Restrictions
none
License
Original content